Hanneke W.M. van Laarhoven

Author

Also Known As

Casper H. J. van Eijck, David J. Heineman, E. Wassenaar, E. van Alphen, Ellen Hendriksen, Evelien J. M. Kuip, H Laarhoven, H W M Laarhoven, H W M Van Laarhoven, H W M van Laarhoven

950

Publications

23.6K

Citations

H-Index

192

Concepts

All Affiliations

University of Amsterdam Radboud University Nijmegen Amsterdam University Medical Centers Radboud University Medical Center Amsterdam UMC Location University of Amsterdam

About

Hanneke W.M. van Laarhoven is an author at University of Amsterdam specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	85	6.8K
2	Health Sciences	24	37	2.1K
3	Nursing	8	8	377
4	Engineering	7	7	712
5	Arts	5	5	238

Hanneke W.M. van Laarhoven

311

Publications

17.1K

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof, The Lancet Oncology Surgical OncologyNeoadjuvant ChemoradiotherapyEsophageal CancerGastrointestinal OncologyMedicine	2015	2.5K
Venous thromboembolism in cancer patients: a population-based cohort study Frits I. Mulder, Erzsébet Horváth–Puhó, Nick van Es, Blood	2020	641
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken, The Lancet Oncology Surgical OncologyChemotherapy Versus ChemoradiotherapyGastrointestinal OncologyResectable Gastric CancerMedicine	2018	562
Artificial reporter gene providing MRI contrast based on proton exchange Assaf A. Gilad, Michael T. McMahon, Piotr Walczak, Nature Biotechnology Nuclear ImagingEngineeringMedical ImagingImaging AgentsArtificial Reporter Gene	2007	402
The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength Margreet Worm-Smeitink, Marieke Gielissen, Lotte Bloot, Journal of Psychosomatic Research Physical ActivityKinesiologyFatigue ManagementChecklist Individual StrengthExercise	2017	358
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial Charles S. Fuchs, Kohei Shitara, Maria Di Bartolomeo, The Lancet Oncology First-line TherapyGastrointestinal OncologyMedicinePathologyMetastatic Gastric	2019	276
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT) Tom van den Ende, Nicolien C. de Clercq, Mark I. van Berge Henegouwen, Clinical Cancer Research	2021	267
The Cancer Worry Scale José A. E. Custers, Sanne W. van den Berg, Hanneke W.M. van Laarhoven, Cancer Nursing	2013	224
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer Alessandro Leal, Nicole C.T. van Grieken, Doreen N. Palsgrove, Nature Communications	2020	222
Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma Eva A. Ebbing, Amber P. van der Zalm, Anne Steins, Proceedings of the National Academy of Sciences Esophageal CancerImmunologyPathologyImmunotherapyStromal-derived Interleukin 6	2019	194

Page 1